Search

Your search keyword '"Dobay, Maria Pamela"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Dobay, Maria Pamela" Remove constraint Author: "Dobay, Maria Pamela"
44 results on '"Dobay, Maria Pamela"'

Search Results

2. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

3. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

4. Metagenomics, Resources

7. DDBJ Genome Resources

9. Metabolic Disease Resources

10. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

11. EBI Genome Resources

14. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability

16. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7

17. TNF receptor 2 is essential for RIP1-dependent cell death in refractory leukemia

18. Longitudinal Multilevel Omic Analysis of Pediatric T-ALL Reveals Distinct Mechanisms for Disease Progression in Type 1 and in Type 2 Relapses

19. Abstract 4321: TNF receptor 2 is essential for RIP1-dependent cell death in refractory leukemia

21. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

24. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

25. Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

26. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

28. Drug Response Profiling to Identify Selective Pharmacological Activity in Drug Resistant ALL

29. Abstract 493: Drug response profiling to inform individualized treatment approaches in high risk leukemia

30. Relapsing Pediatric T-Cell Acute Lymphoblastic Leukemia Downregulates T-Cell Properties and Upregulates Cell Adhesion

33. NCBI viral genomes resources

34. DDBJ genome resources

35. Metagenomics resources

36. NCBI BioProject genome resources

37. Metabolic disease resources

38. EBI genome resources

41. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.

42. Relapsing Pediatric T-Cell Acute Lymphoblastic Leukemia Downregulates T-Cell Properties and Upregulates Cell Adhesion

43. Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

44. Optimized Protein-Protein Interaction Network Usage with Context Filtering.

Catalog

Books, media, physical & digital resources